Eurazeo China Acceleration Fund (ECAF) has invested €80m in vitreoretinal surgery Dutch Ophthalmic Research Center (DORC), which is a portfolio company of Eurazeo Capital IV.
Eurazeo China Acceleration Fund (ECAF) has invested €80m in vitreoretinal surgery Dutch Ophthalmic Research Center (DORC), which is a portfolio company of Eurazeo Capital IV.